Eli Lilly and Company, Q2 FY2026LLLLY+48%Q2 FY2026Eli Lilly and CompanyEli Lilly and Company Q2 FY2026 income flowRevenue $23.0B, gross margin 85.8%, net margin 30.9%.
Johnson & Johnson, Q2 FY2026JNJNJ+6.6%Q2 FY2026Johnson & JohnsonJohnson & Johnson Q2 FY2026 income flowRevenue $25.3B, gross margin 73.1%, net margin 21.9%.Revenue$25.3BGross73.1%Net21.9%
Pfizer Inc., Q2 FY2026PFPFE+2.6%Q2 FY2026Pfizer Inc.Pfizer Inc. Q2 FY2026 income flowRevenue $15.0B, gross margin 72.8%, net loss $246.0M.Revenue$15.0BGross72.8%Net loss$246.0M